基本信息
浏览量:401
职业迁徙
个人简介
Since 5 decades, Prof. Schmoll is highly esteemed, accepted and the most relevant and influential medical oncologist in Germany: a clinical scientist in many fields of medical-oncology, with exceptional leadership and influence for the development of medical oncology in germany, and academic teacher, who educated generations of medical oncologist in germany and many other contries. As editor of the german standard reference book for medical and multidisciplinary oncology (6000 pages), he defined over the last 30 years the treatment standards and education in medical oncology in the german speaking countries and also as founder and chair of several international consensus conferences and guidelines author - in particular for testicular- and colorectal cancer.
He has contributed over the last decades continuously as key researcher to the whole field of medical oncology, in particular 5 in GU and GI-cancer, with numerous standard setting national and international trials, mostly within the EORTC, AIO or large international cooperation. His work has defined worldwide standards, in particular for the adjuvant treatment of colon and rectal cancer and the management of germcell cancer and has been highly cited, with a cum. IF >1758, a citation rate of 1500-1700/year, and a correspondingly h-citation factor of 76 (web os science) - reflecting the international relevance of his research.
In Germany, he has since the early 80ties successfully set up the structures for cooperative and multidisciplinary clinical research, with large nationwide trials in GI-and GU-cancer. He developed in the last 2 decades the setting oft he AIO with 30 cooperative Clinical Trials Groups for all tumor types, what formed the basis for the current international acceptance of the AIO as one of the world´s leading clinical trials group, and in particular also for the scientific and professional development of the younger generation. Eg., many of his former fellows achieved a high level of international recognition.
Prof. Schmoll was also instrumental for the european recognition of “med-onc” by forming a “political” coalition to change the negative voting of germany in the EU. Within ESMO, he served in the Executive Board as chair of the Multidisciplinary Oncology Committee (MOC), and as scientific chair of the Istanbul ESMO Congress 2006 where he developed the current program-committee organisation with tumor-traks etc.
Prof. Schmoll is still highly active in clinical research, high ranked publications and teaching scientific organisations.
He has contributed over the last decades continuously as key researcher to the whole field of medical oncology, in particular 5 in GU and GI-cancer, with numerous standard setting national and international trials, mostly within the EORTC, AIO or large international cooperation. His work has defined worldwide standards, in particular for the adjuvant treatment of colon and rectal cancer and the management of germcell cancer and has been highly cited, with a cum. IF >1758, a citation rate of 1500-1700/year, and a correspondingly h-citation factor of 76 (web os science) - reflecting the international relevance of his research.
In Germany, he has since the early 80ties successfully set up the structures for cooperative and multidisciplinary clinical research, with large nationwide trials in GI-and GU-cancer. He developed in the last 2 decades the setting oft he AIO with 30 cooperative Clinical Trials Groups for all tumor types, what formed the basis for the current international acceptance of the AIO as one of the world´s leading clinical trials group, and in particular also for the scientific and professional development of the younger generation. Eg., many of his former fellows achieved a high level of international recognition.
Prof. Schmoll was also instrumental for the european recognition of “med-onc” by forming a “political” coalition to change the negative voting of germany in the EU. Within ESMO, he served in the Executive Board as chair of the Multidisciplinary Oncology Committee (MOC), and as scientific chair of the Istanbul ESMO Congress 2006 where he developed the current program-committee organisation with tumor-traks etc.
Prof. Schmoll is still highly active in clinical research, high ranked publications and teaching scientific organisations.
研究兴趣
论文共 628 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Claire Gallois,Qian Shi,Levi D Pederson,Thierry André,Timothy J Iveson,Alberto F Sobrero,Steven Alberts,Aimery de Gramont,Jeffrey A Meyerhardt,Thomas George,Hans-Joachim E Schmoll,Ioannis Souglakos,Andrea Harkin,Roberto Labianca,Frank A Sinicrope,Eiji Oki,Anthony F Shields,Ioannis Boukovinas,Rachel Kerr, Sara Lonardi,Greg Yothers,Takayuki Yoshino,Richard M Goldberg,Julien Taieb,Demetris Papamichael
Journal of Clinical Oncologyno. 19 (2024): 2295-2305
Benoist Chibaudel, Morteza Raeisi, Romain Cohen, Greg Yothers,Richard M Goldberg, Jean-Baptiste Bachet,Norman Wolmark,Takayuki Yoshino,Hans-Joachim Schmoll,Rachel Kerr, Sara Lonardi,Thomas J George, Einat Shacham-Shmueli,Qian Shi,Thierry André,Aimery de Gramont
Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2400394-JCO2400394, (2024)
European journal of cancer (2023): 137-150
Fang-Shu Ou,Daniel H. Ahn,Jesse G. Dixon,Axel Grothey,Yiyue Lou,Pashtoon M. Kasi,Joleen M. Hubbard,Eric Van Cutsem,Leonard B. Saltz,Hans-Joachim Schmoll,Richard M. Goldberg,Alan P. Venook,Paulo Hoff,Jean-Yves Douillard,J. Randolph Hecht,Herbert Hurwitz,Cornelis J. A. Punt,Miriam Koopman,Carsten Bokemeyer,Charles S. Fuchs,Eduardo Diaz-Rubio,Niall C. Tebbutt,Chiara Cremolini,Fairooz F. Kabbinavar,Tanios Bekaii-Saab,Benoist Chibaudel,Takayuki Yoshino,John Zalcberg,Richard A. Adams,Aimery de Gramont,Qian Shi
Hans-Joachim Schmoll,Julia Mann,Fabian Meinert,Benjamin Garlipp,Kersten Borchert,Arndt Vogel,Eray Goekkurt,Ulrich Kaiser,Heinz-Gert Hoeffkes,Jörn Rüssel,Stephan Kanzler,Thomas Edelmann,Helmut Forstbauer,Thomas Göhler,Carla Hannig,Bert Hildebrandt, Carsten Roll,Carsten Bokemeyer,Jörg Steighardt,Franziska Cygon,Stefan Ibach,Alexander Stein,Joseph Tintelnot
British journal of cancer (2023)
B. Chibaudel,M. Raeisi,T. Andre,G. Yothers,H. Schmoll,J. Bachet,R. Cohen, N. Wolmark,T. Yoshino,R. Goldberg,R. Kerr,S. Lonardi,T. George,E. Shacham-Shmueli, L. Sharara,Q. Shi,A. de Gramont
加载更多
作者统计
#Papers: 627
#Citation: 28091
H-Index: 83
G-Index: 157
Sociability: 9
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn